Abstract
Background In observational studies, the risk of immortal time bias (ITB) increases with the likelihood of early death, itself increasing with age. We investigated how age impacts the magnitude of ITB when estimating the effect of surgery on one-year overall survival (OS) in patients with stage IV colon cancer aged 50-74 and 75-99 in England.
Method Using simulations, we compared estimates from a time-fixed exposure model to three methods addressing ITB: time-varying exposure, delayed entry, and landmark methods. We then estimated the effect of surgery on one-year OS using a national population-based cohort of patients derived from the CORECT-R resource.
Results In simulations, the magnitude of ITB was larger among older patients when their probability of early death increased or treatment was delayed. The bias was corrected using the methods addressing ITB. When applied to CORECT-R data, these methods yielded smaller effects than the time-fixed exposure approach but effects were similar in both age groups.
Conclusion ITB must be addressed in all longitudinal studies, particularly, when investigating the effect of an exposure on an outcome in different groups of people (e.g., age groups) with different distributions of exposure and outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SP was supported by the European Union's Horizon 2020 Research. and Innovation Programme, Belgium under the Marie Skłodowska-Curie grant agreement No 842817. CL is supported by the UK Medical Research Council (Skills Development Fellowship MR/T032448/1). CM is supported through the Cancer Research UK Population Research Committee Funding Scheme: Cancer Research UK Population Research Committee - Programme Award (C7923/A29018). This work was supported by Cancer Research UK (C23434/A23706), which underpinned data access via the UK Colorectal Cancer Intelligence Hub.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The project is covered by the Establishing a UK Colorectal Cancer Intelligence Hub Research Ethics approval (18/SW/1034) granted by the South West, Central Bristol Research Ethics Committee on the 1st June 2018. The study was performed in accordance with the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
CORECT-R data are available upon request at https://www.ndph.ox.ac.uk/corectr/corect-r.
